<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activating mutations in FGFR3 cause <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> and thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, the most common human <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In these disorders, spinal canal and <z:hpo ids='HP_0005468'>foramen magnum stenosis</z:hpo> can cause serious neurologic complications </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we provide evidence that FGFR3 and MAPK signaling in chondrocytes promote synchondrosis closure and fusion of ossification centers </plain></SENT>
<SENT sid="3" pm="."><plain>We observed premature synchondrosis closure in the spine and cranial base in human cases of homozygous <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> and thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath> as well as in mouse models of <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In both species, premature synchondrosis closure was associated with increased bone formation </plain></SENT>
<SENT sid="5" pm="."><plain>Chondrocyte-specific activation of Fgfr3 in mice induced premature synchondrosis closure and enhanced osteoblast differentiation around synchondroses </plain></SENT>
<SENT sid="6" pm="."><plain>FGF signaling in chondrocytes increases Bmp ligand <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression and decreases Bmp <z:chebi fb="68" ids="48706">antagonist</z:chebi> <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in a MAPK-dependent manner, suggesting a role for Bmp signaling in the increased bone formation </plain></SENT>
<SENT sid="7" pm="."><plain>The enhanced bone formation would accelerate the fusion of ossification centers and limit the endochondral bone growth </plain></SENT>
<SENT sid="8" pm="."><plain>Spinal canal and <z:hpo ids='HP_0005468'>foramen magnum stenosis</z:hpo> in heterozygous <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> patients, therefore, may occur through premature synchondrosis closure </plain></SENT>
<SENT sid="9" pm="."><plain>If this is the case, then any growth-promoting treatment for these complications of <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> must precede the timing of the synchondrosis closure </plain></SENT>
</text></document>